This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kensler, T. W. Articles by Groopman, J. D. Search for Related Content PubMed PubMed Citation Articles by Kensler, T. W. Articles by Groopman, J. D.

Modulation of Aflatoxin Metabolism, Aflatoxin-N⁷-guanine Formation, and Hepatic Tumorigenesis in Rats Fed Ethoxyquin: Role of Induction of Glutathione S-Transferases¹

Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205 [T. W. K., P. A. E.]; Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20205 [N. E. D.]; Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755 [B. D. R.]; and Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts 02118 [A. P., J. D. G.]

The effects of dietary administration of ethoxyquin (EQ) on aflatoxin B₁ (AFB₁) metabolism, DNA adduct formation and removal, and hepatic tumorigenesis were examined in male Fischer rats. Rats were fed a semipurified diet containing 0.4% EQ for 1 wk, gavaged with 250 µg of AFB₁ per kg 5 times a wk during the next 2 wk, and, finally, restored to the control diet 1 wk after cessation of dosing. At 4 mo, focal areas of hepatocellular alteration were identified and quantitated by staining sections of liver for -glutamyl transpeptidase. Treatment with EQ reduced by >95% both area and volume of liver occupied by -glutamyl transpeptidase-positive foci. Utilizing the same multiple dosing protocol, patterns of covalent modifications of DNA by AFB₁ were determined. EQ produced a dramatic reduction in the binding of AFB₁ to hepatic DNA: 18-fold initially and 3-fold at the end of the dosing period. Although binding was detectable at 3 and 4 mo postdosing, no effect of EQ was observed, suggesting that these persistent adducts are not of primary relevance to AFB₁ carcinogenesis. Analysis of nucleic acid bases by high-performance liquid chromatography revealed no qualitative differences in adduct species between treatment groups. The inhibitory effect of EQ on AFB₁ binding to DNA and tumorigenesis appears related to induction of detoxication enzymes. Rats fed 0.4% EQ for 7 days showed a 5-fold increase in hepatic cytosolic glutathione S-transferase (GST)-specific activities. Multiple molecular forms of GST were induced, and concomitant elevations in messenger RNA levels coding for the synthesis of GST subunits were observed. Correspondingly, biliary elimination of AFB₁-glutathione conjugate was increased 4.5-fold in animals on the EQ diet during the first 2 h following p.o. administration of 250 µg of AFB₁ per kg. Thus, induction by EQ of enzymes important to AFB₁ detoxication, such as GST, can lead to enhanced carcinogen elimination, as well as reductions of AFB₁-DNA adduct formation and subsequent expression of preneoplastic lesions, and, ultimately, neoplasia.

¹ Supported by grants from the American Cancer Society (SIG-3 and BC-477) and USPHS (CA-39416).

² To whom requests for reprints should be addressed.

Received 2/28/86. Accepted 5/ 7/86.

This article has been cited by other articles:

				M. T. Simonich, P. A. Egner, B. D. Roebuck, G. A. Orner, C. Jubert, C. Pereira, J. D. Groopman, T. W. Kensler, R. H. Dashwood, D. E. Williams, et al. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat Carcinogenesis, June 1, 2007; 28(6): 1294 - 1302. [Abstract] [Full Text] [PDF]

				Y. R. Pokharel, E. H. Han, J. Y. Kim, S. J. Oh, S. K. Kim, E.-R. Woo, H. G. Jeong, and K. W. Kang Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A Carcinogenesis, December 1, 2006; 27(12): 2483 - 2490. [Abstract] [Full Text] [PDF]

				H. S El-Nezami, N. N Polychronaki, J. Ma, H. Zhu, W. Ling, E. K Salminen, R. O Juvonen, S. J Salminen, T. Poussa, and H. M Mykkanen Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1199 - 1203. [Abstract] [Full Text] [PDF]

				T. W. Kensler, J.-G. Chen, P. A. Egner, J. W. Fahey, L. P. Jacobson, K. K. Stephenson, L. Ye, J. L. Coady, J.-B. Wang, Y. Wu, et al. Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2605 - 2613. [Abstract] [Full Text] [PDF]

				L. L. Bedard, M. Alessi, S. Davey, and T. E. Massey Susceptibility to Aflatoxin B1-Induced Carcinogenesis Correlates with Tissue-Specific Differences in DNA Repair Activity in Mouse and in Rat Cancer Res., February 15, 2005; 65(4): 1265 - 1270. [Abstract] [Full Text] [PDF]

				B. D. Roebuck, T. J. Curphey, Y. Li, K. J. Baumgartner, S. Bodreddigari, J. Yan, S. J. Gange, T. W. Kensler, and T. R. Sutter Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz Carcinogenesis, December 1, 2003; 24(12): 1919 - 1928. [Abstract] [Full Text] [PDF]

				R. E. Sotomayor, M. Washington, L. Nguyen, R. Nyang'anyi, D. M. Hinton, and M. Chou Effects of Intermittent Exposure to Aflatoxin B1 on DNA and RNA Adduct Formation in Rat Liver: Dose-Response and Temporal Patterns Toxicol. Sci., June 1, 2003; 73(2): 329 - 338. [Abstract] [Full Text] [PDF]

				D. M. Kuhn and M. A. Ghannoum Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective Clin. Microbiol. Rev., January 1, 2003; 16(1): 144 - 172. [Abstract] [Full Text] [PDF]

				C.P. Wild and P.C. Turner The toxicology of aflatoxins as a basis for public health decisions Mutagenesis, November 1, 2002; 17(6): 471 - 481. [Abstract] [Full Text] [PDF]

				T. K. Bammler, D. H. Slone, and D. L. Eaton Effects of Dietary Oltipraz and Ethoxyquin on Aflatoxin B1 Biotransformation in Non-Human Primates Toxicol. Sci., March 1, 2000; 54(1): 30 - 41. [Abstract] [Full Text] [PDF]

				W. R. Fields, C. S. Morrow, J. Doehmer, and A. J. Townsend Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1 Carcinogenesis, June 1, 1999; 20(6): 1121 - 1125. [Abstract] [Full Text] [PDF]

				J. D. Groopman and T. W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis, January 1, 1999; 20(1): 1 - 11. [Full Text] [PDF]

				W. R. Fields, C. S. Morrow, A. J. Doss, K. Sundberg, B. Jernström, and A. J. Townsend Overexpression of Stably Transfected Human Glutathione S-Transferase P1-1 Protects against DNA Damage by Benzo[a]pyrene Diol-Epoxide in Human T47D Cells Mol. Pharmacol., August 1, 1998; 54(2): 298 - 304. [Abstract] [Full Text]